Intellia Therapeutics Aktie
9,76
EUR
-0,33
EUR
-3,23
%
11,64
USD
-0,36
USD
-2,96
%
Werbung
Intellia Therapeutics Aktie Analyse
| 02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
| 31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung